Cardinal Health (NYSE: CAH) shares dropped sharply by 5.49% to $149.00 in pre-market trading on August 12, 2025, following the company’s Q4 earnings release.
Despite reporting a 13% increase in EPS from last year and slightly surpassing estimates, revenue fell short of expectations by approximately $740 million.
Additionally, CAH announced a major $1.9 billion acquisition of Solaris Health which might have influenced investor sentiment due to the significant cash outlay and strategic implications. The acquisition, expected to close by end of 2025, aims to boost Cardinal’s presence in the specialty sector.
